Livanov G A, Shikalova I A, Lodyagin A N, Glushkov S, Batotsyrenov B V, Loladze A T, Kovalenko A L
Eksp Klin Gastroenterol. 2016(5):45-50.
The aim of the study was to increase the efficiency of the treatment of acute ethanol intoxication in patients with alcoholic fatty liver disease. The article presents the results which received during the investigation and treatment of 166 patients with acute ethanol in- toxication on the background of alcoholic fatty liver disease Patients were assessed by the severity scale APACHE-Il. Were studied the dynamics of clinical, laboratory, biochemical parameters, the state of the antioxidant system activity and lipid peroxidation. The study found the effect of the combination hepatoprotective drug remaxol on the many links of metabolism, which was confirmed by the dynamics of biochemical parameters. There was a quick correction of hyperlactatemia, an effective reduction of ALT activity, the absence of reduction of albumin and urea concentration in the somatic period of ethanol poisoning. Period of using remaxol there was improvement in the clinical course of the disease, which manifested by the reduce the incidence of delirium tremens and shorten the duration of treatment of patients.
该研究的目的是提高酒精性脂肪肝病患者急性乙醇中毒的治疗效率。本文介绍了对166例酒精性脂肪肝病背景下急性乙醇中毒患者进行调查和治疗期间所获得的结果。通过APACHE-II严重程度量表对患者进行评估。研究了临床、实验室、生化参数的动态变化、抗氧化系统活性状态和脂质过氧化情况。研究发现,肝保护药物瑞马克索组合对代谢的多个环节有影响,这一点通过生化参数的动态变化得到证实。在乙醇中毒的躯体期,高乳酸血症得到快速纠正,ALT活性有效降低,白蛋白和尿素浓度没有降低。使用瑞马克索期间,疾病的临床病程有所改善,表现为震颤谵妄的发生率降低,患者治疗时间缩短。